ITGB1 has been proposed as a direct target of repression by miR-183 in cervical [55] and endometrial cancer [56], but in both tissues miR-183 acts as a tumor suppressor causing upregulation of the invasiveness promoter ITGB1. This evidence concerns the gene ITGB1 and neoplasm.